Closely observe patients for signs of hypomagnesemia, including muscle weakness, tremors, and arrhythmias. Monitor magnesium levels regularly, especially in patients at risk.
Assess for signs of Clostridium difficile infection (CDI), such as diarrhea and abdominal pain. Report any suspected cases immediately.
Regularly check vital signs, paying particular attention to heart rate and rhythm. Report any significant changes to the prescribing physician.
Continuously monitor intravenous infusion site for signs of phlebitis or infiltration, including redness, swelling, and pain. Immediately discontinue infusion if complications arise and initiate appropriate treatment.
Carefully document all observations and interventions in the patient’s medical record. Include details of any adverse reactions observed.
Patients with renal impairment require close monitoring of Pantoprazole levels and renal function. Adjust dosages as needed per the physician’s orders.
Assess patients for the development of pneumonia. Increased risk factors should be considered when initiating treatment. Early detection and management can improve outcomes.
Pay close attention to patient complaints and address them promptly. Any unusual symptoms warrant immediate physician notification.
Remember: This information is for educational purposes and does not replace a healthcare professional’s judgment. Always consult the latest drug information and follow established protocols.
